Zepp Health Corporation (ZEPP) Announces Investment in Promaxo

Promaxo, Inc. (Promaxo), the medical imaging, robotics, and AI technology company, and Zepp Health (NYSE: ZEPP), a leading global developer of smart health technology, today announced additional investments in Promaxo. Promaxo and Zepp Health will also continue to deepen their commercial partnership by sharing artificial intelligence resources, setting up new product manufacturing opportunities, and seeking China Food and Drug Administration (CFDA) regulatory approval.

“We are pleased to have strategic investors, such as Zepp Health, as we commercialize our truly open MRI system to the broader physician office community,” said Dr. Amit Vohra, Founder and CEO of Promaxo. “Zepp Health’s financial support is a welcome contribution as we execute on our vision and advance MR guided diagnosis and treatment options to our patients and clinical partners.”

Promaxo plans to use the funds to accelerate commercialization of its artificial intelligence in imaging and image-based interventions. Promaxo’s patient-centric approach aims to provide patients with cutting-edge technology as it works to expand the frontiers of knowledge in the fields of medical imaging, robotics, and artificial intelligence.

“Zepp Health's mission is to connect health with technology, and we see tremendous opportunity in imaging as we expand our footprint in the health technology space. Companies such as Promaxo are disrupting the locations, applications, and costs of medical imaging. Zepp Health has resources, such as miniaturization engineering expertise, that can help accelerate Promaxo’s growth and success, and we look forward to what our partnership can develop,” said Zepp Health COO Mike Yeung.

Zepp Health's Vice President of Business and Corporate Development, Tim Houchin, added, "Zepp Health has become a global leader in consumer health technology. These partnerships with diagnostic healthcare technologies present new financial and market opportunities for our business to expand into industrial medical technology."

You May Also Be Interested In

• Flex (FLEX) Reports Acquisition of FreeFlow
• Day One (DAWN) Sells Priority Review Voucher for $108M
• Invivyd (IVVD) Appoints Timothy Lee as Chief Commercial Officer